S. Nonoyama et al., DIMINISHED EXPRESSION OF CD40 LIGAND MAY CONTRIBUTE TO THE DEFECTIVE HUMORAL IMMUNITY IN PATIENTS WITH MHC CLASS-II DEFICIENCY, European Journal of Immunology, 28(2), 1998, pp. 589-598
Major histocompatibility complex (MHC) class II deficiency (bare lymph
ocyte syndrome, BLS) is a rare primary immunodeficiency classified as
a subgroup of severe combined immunodeficiency. We studied T and B lym
phocyte function by examining the CD40 ligand/CD40 system in three BLS
patients from two unrelated families. CD40 ligand expression by maxim
ally activated BLS T cells was diminished. This abnormality may repres
ent immunological naivete rather than a general T cell defect, since e
xpression of activation marker CD69 and proliferative responses to PHA
or anti-CD3 were normal, and BLS T cells primed and restimulated in v
itro expressed normal amounts of CD40 ligand. BLS B cells proliferated
and produced IgE if stimulated with anti-CD40 or soluble CD40 ligand
and IL-4. Activation of BLS B cells with soluble CD40 ligand and IL-4
induced normal expression of activation markers, although MHC class II
expression remained absent. Depressed antibody titers, lack of amplif
ication and failure to undergo isotype switching in response to immuni
zation with bacteriophage Phi x 174 demonstrated defective T cell help
. We conclude that BLS B cells are functionally normal if appropriatel
y stimulated, and that the defective humoral immunity observed may be
related to diminished expression of CD40 ligand on BLS T cells.